Quote:
Originally Posted by pip08456
But the statiscs! It's always about statistics!!!!
|
Here you go, some statistics;
Quote:
|
However, based on pre-COVID figures it was calculated that less than 1 reported case of DIC might have been expected by 16 March among people under 50 within 14 days of receiving the vaccine, whereas 5 cases had been reported. Similarly, on average 1.35 cases of CVST might have been expected among this age group whereas by the same cut-off date there had been 12. A similar imbalance was not visible in the older population given the vaccine.
|
From todays EMA report -
https://www.ema.europa.eu/en/news/co...re-blood-clots
So 5x higher risk of disseminated intravascular coagulation, DIC and just under 10x higher risk of cerebral venous sinus thrombosis, CVST in vaccinated under 50s.
However, the conclusion is;
Quote:
|
The Committee was of the opinion that the vaccine’s proven efficacy in preventing hospitalisation and death from COVID-19 outweighs the extremely small likelihood of developing DIC or CVST. However, in the light of its findings, patients should be aware of the remote possibility of such syndromes, and if symptoms suggestive of clotting problems occur patients should seek immediate medical attention and inform healthcare professionals of their recent vaccination. Steps are already being taken to update the product information for the vaccine to include more information on these risks.
|
So there's a low risk of clotting but it's higher than background and worth the risk considering the risks of COVID infections